Hikal News and Updates

Name: Latest research reports of Hikal Ltd. authored by BP Wealth and published by - Trendlyne research reports.
Item: Hikal Ltd.
Rating: 1
Author: BP Wealth

Keep track of all breaking news on Hikal from all sources in a single place.

Load latest

Hikal Ltd.

07 May 2021

243.25

0.52%

Hikal Consolidated March 2021 Net Sales at Rs 532.46 crore, up 40.49% Y-o-Y

Moneycontrol

NULL

Hikal Ltd. is trading below its 100 day SMA of 252.1

Hikal Ltd.

05 May 2021

243.25

0.52%

Hikal in 10-year multi-product deal with global player

Business Line

To develop and supply APIs from Panoli plant; stock hits upper circuit

Hikal has lost -31.89% in the last 6 Months

Hikal hits upper circuit after it signs a multi-year deal

Economic Times | 05 May 2021 1 more

Hikal Ltd.

17 Apr 2021

243.25

0.52%

Trading pick of the week: Hikal (179.6): Buy

Business Line

Investors with a medium-term perspective can buy the stock of Hikal, a small-cap pharmaceuticals company, at current levels. The company offers solut

Hikal Ltd. is trading below its 100 day SMA of 252.1

Hikal Ltd.

04 Feb 2021

243.25

0.52%

Hikal Consolidated December 2020 Net Sales at Rs 463.29 crore, up 14.66% Y-o-Y

Moneycontrol

NULL

Hikal has lost -31.89% in the last 6 Months

Hikal's profit after tax rises 42.8% to Rs 40 crore in December quarter

Business Standard | 04 Feb 2021

Hikal Ltd.

03 Dec 2020

243.25

0.52%

Why should investors look at Hikal?

Moneycontrol

One of the key aspects we like about Hikal is its efforts towards operational risk management

Number of FII/FPI investors decreased from 104 to 67 in Sep 2025 qtr

Hikal Ltd.

07 Nov 2020

243.25

0.52%

Buy Hikal; target of Rs 230: ICICI Direct

Moneycontrol

ICICI Direct is bullish on Hikal has recommended buy rating on the stock with a target price of Rs 230 in its research report dated November 05, 2020.

Hikal Ltd. is trading below its 100 day SMA of 252.1

Hikal Ltd.

06 Nov 2020

243.25

0.52%

BP Equities Hikal Ltd Q2FY21 Result Update

Sell: Hikal Ltd.

BP Wealth

INR3,368mn mainly driven by strong growth in the Pharmaceutical segment. On segmental performance: The crop protection segment de grew by 17.9% (YoY) to INR 926mn and 12.7% (YoY) due to deferment of orders worth INR400mn which is expected to be supplied largely in Q3FY21. Pharmaceutical segment revenue surged by 34.1% to INR 2,793mn led by strong volume off-take supported by new capacity at Bangalore unit which was commissioned late last year. Despite 554bps contraction in gross margin, EBITDA margin managed to improve by 58bps to18.8%, was 29bps above our estimate. EBITDA margin was supported by 11% (YoY) decline in employee cost and flat other expenses in the growing topline. EBIT margin of the Crop protection segment declined by 1044bps...

Hikal has lost -33.59% in the last 1 Year

Hikal Ltd.

05 Nov 2020

243.25

0.52%

Hikal Ltd

Buy: Hikal Ltd.

Target

ICICI Securities Limited

Q2FY21 revenues grew a decent 15.8% YoY to | 372 crore on the back of 34.1% YoY growth in pharma segment to | 279 crore. Crop protection segment fell 17.9% YoY to | 93 crore due to deferral of | 40 crore worth of shipment to Q3FY21. EBITDA for the quarter came in at | 70 crore, up 19.6% YoY (including Covid related expenses of | 1.1 crore). EBITDA margins expanded 58 bps YoY to 18.8% due to lower staff & other expenses, partly offset by lower gross margins. Adjusted PAT grew 23.8% YoY to | 27 crore in line with operational performance. Delta vis-a-vis EBITDA was due to...

Number of FII/FPI investors decreased from 104 to 67 in Sep 2025 qtr

Hikal Ltd.

17 Sep 2020

243.25

0.52%

Hikal (183): Buy

Business Line

The stock of Hikal jumped 9.3 per cent accompanied by extra-ordinary volume on Thursday, breaking above a key short-term resistance at 175. This rall

Hikal has lost -33.59% in the last 1 Year

Hikal shares advance 12%, hit 52-week high on growth prospects

Business Standard | 17 Sep 2020

Hikal Ltd.

08 Sep 2020

243.25

0.52%

Hikal: Focus on operational risk management adds to conviction

Moneycontrol

Any protectionist measure from the government, given the recent trend towards ant-dumping duty and Make in India theme could disproportionately benefit the Hikal

Hikal Ltd. is trading below its 100 day SMA of 252.1

Is Hikal Ltd. worth buying?

258 Votes:

Buy 79.07%

Sell 12.79%

Hold 8.14%

46.74% Fall from 52W High

Hikal News and Updates

Keep track of all breaking news on Hikal from all sources in a single place.